Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Moodys
Federal Trade Commission
Express Scripts
Fuji
Dow
Argus Health
Chinese Patent Office
Merck

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,603,506

« Back to Dashboard

Which drugs does patent 8,603,506 protect, and when does it expire?

Patent 8,603,506 protects ORACEA and is included in one NDA.

This patent has seventeen patent family members in twelve countries.
Summary for Patent: 8,603,506
Title:Methods of treating acne
Abstract: A method of treating acne in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound.
Inventor(s): Ashley; Robert A. (Newtown, PA)
Assignee: Galderma Laboratories, Inc. (Fort Worth, TX)
Application Number:13/277,789
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,603,506
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 8,603,506

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galderma Labs Lp ORACEA doxycycline CAPSULE;ORAL 050805-001 May 26, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTULES) OF ROSACEA ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,603,506

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,052,983 Methods of treating acne ➤ Try a Free Trial
9,241,946 Methods of treating acne ➤ Try a Free Trial
7,014,858 Use methods of treating acne and telangiectasia ➤ Try a Free Trial
8,658,189 Methods of treating acne ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,603,506

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Portugal 1383508 ➤ Try a Free Trial
New Zealand 528197 ➤ Try a Free Trial
South Korea 100926326 ➤ Try a Free Trial
South Korea 20040007488 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
QuintilesIMS
Boehringer Ingelheim
Queensland Health
McKinsey
Dow
Express Scripts
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.